These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 33982895)
1. Interleukin-34 Reprograms Glycolytic and Osteoclastic Rheumatoid Arthritis Macrophages via Syndecan 1 and Macrophage Colony-Stimulating Factor Receptor. Van Raemdonck K; Umar S; Palasiewicz K; Volin MV; Elshabrawy HA; Romay B; Tetali C; Ahmed A; Amin MA; Zomorrodi RK; Sweiss N; Shahrara S Arthritis Rheumatol; 2021 Nov; 73(11):2003-2014. PubMed ID: 33982895 [TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming of macrophages instigates CCL21-induced arthritis. Van Raemdonck K; Umar S; Palasiewicz K; Meyer A; Volin MV; Chang HJ; Al-Awqati M; Zomorrodi RK; Shahrara S Immunol Cell Biol; 2022 Feb; 100(2):127-135. PubMed ID: 34779007 [TBL] [Abstract][Full Text] [Related]
3. Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells. Meyer A; Sienes RE; Nijim W; Zanotti B; Umar S; Volin MV; Van Raemdonck K; Lewis M; Pitzalis C; Arami S; Al-Awqati M; Chang HJ; Jetanalin P; Schett G; Sweiss N; Shahrara S Ann Rheum Dis; 2023 Apr; 82(4):483-495. PubMed ID: 36593091 [TBL] [Abstract][Full Text] [Related]
4. Significance of IL-34 and SDC-1 in the pathogenesis of RA cells and preclinical models. Alzoubi O; Meyer A; Gonzalez TP; Burgos AC; Sweiss N; Zomorrodi RK; Shahrara S Clin Immunol; 2023 Jun; 251():109635. PubMed ID: 37150238 [TBL] [Abstract][Full Text] [Related]
5. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis. Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503 [TBL] [Abstract][Full Text] [Related]
6. Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis. Garcia S; Hartkamp LM; Malvar-Fernandez B; van Es IE; Lin H; Wong J; Long L; Zanghi JA; Rankin AL; Masteller EL; Wong BR; Radstake TR; Tak PP; Reedquist KA Arthritis Res Ther; 2016 Mar; 18():75. PubMed ID: 27036883 [TBL] [Abstract][Full Text] [Related]
7. CCL21/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in rheumatoid arthritis. Van Raemdonck K; Umar S; Palasiewicz K; Volkov S; Volin MV; Arami S; Chang HJ; Zanotti B; Sweiss N; Shahrara S Cell Mol Life Sci; 2020 Apr; 77(7):1387-1399. PubMed ID: 31342120 [TBL] [Abstract][Full Text] [Related]
8. Syndecan-1 regulates the biological activities of interleukin-34. Segaliny AI; Brion R; Mortier E; Maillasson M; Cherel M; Jacques Y; Le Goff B; Heymann D Biochim Biophys Acta; 2015 May; 1853(5):1010-21. PubMed ID: 25662098 [TBL] [Abstract][Full Text] [Related]
9. Metabolic regulation of RA macrophages is distinct from RA fibroblasts and blockade of glycolysis alleviates inflammatory phenotype in both cell types. Umar S; Palasiewicz K; Volin MV; Romay B; Rahat R; Tetali C; Arami S; Guma M; Ascoli C; Sweiss N; Zomorrodi RK; O'Neill LAJ; Shahrara S Cell Mol Life Sci; 2021 Dec; 78(23):7693-7707. PubMed ID: 34705053 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 17 under hypoxia mimetic condition augments osteoclast mediated bone erosion and expression of HIF-1α and MMP-9. Samarpita S; Doss HM; Ganesan R; Rasool M Cell Immunol; 2018 Oct; 332():39-50. PubMed ID: 30029761 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis. Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544 [TBL] [Abstract][Full Text] [Related]
12. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis. Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277 [TBL] [Abstract][Full Text] [Related]
13. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis. Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505 [TBL] [Abstract][Full Text] [Related]
14. Effect of heat-reinforcing needling on hypoxia-inducible factor 1α and glycolysis activity in rabbits with cold syndrome of rheumatoid arthritis. Li XJ; Li FX; Jing WY; Liu C; Liu LM; Zhang XH; Zhang FF; Chen P; DU XZ Zhen Ci Yan Jiu; 2024 Jun; 49(6):585-593. PubMed ID: 38897802 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-1α and interleukin 33 form a regulatory circuit to perpetuate the inflammation in rheumatoid arthritis. Hu F; Shi L; Mu R; Zhu J; Li Y; Ma X; Li C; Jia R; Yang D; Li Y; Li Z PLoS One; 2013; 8(8):e72650. PubMed ID: 23967327 [TBL] [Abstract][Full Text] [Related]